Who makes AERAS-402 1.5 x 10^10 vp?

AERAS-402 1.5 x 10^10 vp is developed by Aeras.

What development phase is AERAS-402 1.5 x 10^10 vp in?

AERAS-402 1.5 x 10^10 vp is in Phase 1.

Last reviewed 2026-04-23 · How we verify

AERAS-402 1.5 x 10^10 vp

Aeras · Phase 1 active Biologic

At a glance

Generic name	AERAS-402 1.5 x 10^10 vp
Sponsor	Aeras
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study of AERAS-402 in Healthy Infants (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

AERAS-402 1.5 x 10^10 vp CI brief — competitive landscape report
AERAS-402 1.5 x 10^10 vp updates RSS · CI watch RSS
Aeras portfolio CI